E P van Puijenbroek
University of Groningen
Internal medicineOdds ratioIntensive care medicinePediatricsAdverse effectMedDRAVaccinationInfliximabEtanerceptPregnancyMEDLINEDrugAdverse drug reactionPopulationDrug reactionAnesthesiaFamily medicineFertilityClinical trialPharmacovigilanceMedicinePharmacology
72Publications
10H-index
348Citations
Publications 70
Newest
Background: null Information on adverse drug reactions (ADRs) is generally clustered for all indications of a drug in the patient information leaflet. However, previous research has shown that participants of the Dutch Biologic Monitor (DBM) that use a biologic for their immune-mediated inflammatory disease (IMID) prefer to receive ADR information tailored to their own biologic an IMID (1). Currently, it is unclear whether the ADR profile of a specific biologic may differ between patients with d...
Source
Source
Source
Specialist oncology nurses (SONs) have the potential to play a major role in monitoring and reporting adverse drug reactions (ADRs); and reduce the level of underreporting by current healthcare professionals. The aim of this study was to investigate the long term clinical and educational effects of real-life pharmacovigilance education intervention for SONs on ADR reporting. This prospective cohort study, with a 2-year follow-up, was carried out in the three postgraduate schools in the Netherlan...
2 CitationsSource
SARS-CoV-2 has rapidly spread worldwide since December 2019. Obviously, pregnant and lactating women will also be infected with SARS-CoV-2. Pregnant women, however, are a risk population for developing severe respiratory infections. Currently, the knowledge on potential risks and consequences of COVID-19 during pregnancy and lactation is limited. Available data show that pregnant women suffer from similar symptoms compared to non-pregnant patients. There is no evidence as yet that COVID-19 has a...
#1L. F. Perez-Garcia (EUR: Erasmus University Rotterdam)H-Index: 2
#2Radboud J E M Dolhain (EUR: Erasmus University Rotterdam)H-Index: 28
Last. B. te WinkelH-Index: 2
view all 7 authors...
BACKGROUND Information regarding the possible influence of immunosuppressive drugs on male sexual function and reproductive outcomes is scarce. Men diagnosed with immune-mediated diseases and a wish to become a father represent an important neglected population since they lack vital information to make balanced decisions about their treatment. OBJECTIVE AND RATIONALE The aim of this research was to systematically review the literature for the influence of paternal immunosuppressive drug use on m...
5 CitationsSource
#1N. Ghalandari (Erasmus University Medical Center)H-Index: 1
#2Radboud J E M Dolhain (Erasmus University Medical Center)H-Index: 28
Last. H. J. M. J. CrijnsH-Index: 1
view all 6 authors...
textabstractBackground: Inflammatory autoimmune diseases are chronic diseases that often affect women of childbearing age. Therefore, detailed knowledge of the safety profile of medications used for management of inflammatory autoimmune diseases during pregnancy is important. However, in many cases the potential harmful effects of medications (especially biologics) during pregnancy (and lactation) on mother and child have not been fully identified. Objective: Our aim was to update the data on th...
3 CitationsSource
#1M.O. Reumerman (VUMC: Vanderbilt University Medical Center)H-Index: 1
#2E P van Puijenbroek (UG: University of Groningen)H-Index: 10
Last. M A van Agtmael (VUMC: Vanderbilt University Medical Center)H-Index: 1
view all 4 authors...
The law requires that healthcare professionals adequately inform patients about possible side effects when they prescribe new pharmacological treatments. There are several reasons (lack of time, fear of nocebo effect, patient and prescriber preferences) why informing patients in detail could be undesirable or even harmful. Prescribers should focus on two types of side effects: (a) common side effects with significant impact on the quality of life and (b) side effects that should be recognised in...
#1Michael Ceulemans (Katholieke Universiteit Leuven)H-Index: 5
Last. E P van PuijenbroekH-Index: 10
view all 6 authors...
SARS-CoV-2 has rapidly spread worldwide since December 2019. Obviously, pregnant and lactating women will also be infected with SARS-CoV-2. Pregnant women, however, are a risk population for developing severe respiratory infections. Currently, the knowledge on potential risks and consequences of COVID-19 during pregnancy and lactation is limited. Available data show that pregnant women suffer from similar symptoms compared to non-pregnant patients. There is no evidence as yet that COVID-19 has a...